David G Maloney Selected Research

Transplantation

1/2021	Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.
1/2021	Antibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignancies.
10/2020	Impact of Rituximab and Host/Donor Fc Receptor Polymorphisms after Allogeneic Hematopoietic Cell Transplantation for CD20+ B Cell Malignancies.
1/2020	Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial.
12/2015	Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors.
9/2015	Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma.
10/2014	A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation.
9/2014	Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndrome.
6/2014	Myeloablative I-131-tositumomab with escalating doses of fludarabine and autologous hematopoietic transplantation for adults age ≥ 60 years with B cell lymphoma.
2/2014	Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David G Maloney Research Topics

Disease

59	Neoplasms (Cancer) 12/2022 - 01/2002
30	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 02/2002
29	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 09/2002
28	Lymphoma (Lymphomas) 12/2022 - 05/2002
23	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 01/2003
22	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 01/2003
18	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021 - 01/2003
15	B-Cell Lymphoma (Lymphoma, B Cell) 12/2022 - 07/2006
13	Infections 12/2022 - 01/2002
13	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2020 - 05/2002
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 01/2003
8	Multiple Myeloma 01/2019 - 01/2003
7	Cytokine Release Syndrome 12/2022 - 11/2017
6	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 09/2008
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 08/2011
6	Disease Progression 01/2020 - 06/2008
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 09/2007
5	Cytopenia 12/2022 - 12/2011
5	Thrombocytopenia (Thrombopenia) 12/2022 - 05/2003
5	Neutropenia 12/2022 - 05/2003
5	Residual Neoplasm 11/2019 - 01/2002
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019 - 02/2008
3	Agammaglobulinemia (Hypogammaglobulinemia) 10/2021 - 01/2020
3	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2018 - 01/2005
3	Pathologic Complete Response 02/2016 - 06/2005
2	Anemia 12/2022 - 12/2011
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2019 - 02/2008
2	Bronchiolitis Obliterans Syndrome 01/2015 - 10/2008
2	Lymphopenia (Lymphocytopenia) 05/2013 - 12/2004
2	Burkitt Lymphoma (Burkitt's Lymphoma) 02/2013 - 11/2008
2	Leukemia 06/2010 - 10/2003
2	Systemic Scleroderma (Systemic Sclerosis) 12/2008 - 12/2004
2	Multiple Sclerosis 12/2008 - 12/2004
2	Acute Kidney Injury (Acute Renal Failure) 03/2005 - 07/2004
2	Cytomegalovirus Infections (Inclusion Disease) 11/2003 - 03/2002
1	Hemorrhage 12/2022
1	Virus Diseases (Viral Diseases) 10/2021
1	Lung Neoplasms (Lung Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

35	Chimeric Antigen ReceptorsIBA 12/2022 - 11/2010
31	fludarabineIBA 01/2022 - 02/2003
29	Rituximab (Mabthera)FDA Link 10/2020 - 02/2002
11	Monoclonal AntibodiesIBA 01/2022 - 05/2002
10	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021 - 03/2002
9	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021 - 03/2002
9	AntigensIBA 08/2019 - 03/2002
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 05/2002
6	axicabtagene ciloleucelIBA 12/2022 - 01/2020
6	AntibodiesIBA 01/2021 - 02/2002
6	CD19-specific chimeric antigen receptorIBA 11/2019 - 01/2016
5	Pharmaceutical PreparationsIBA 10/2017 - 02/2002
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2022 - 05/2003
4	Sirolimus (Rapamycin)FDA Link 01/2021 - 10/2014
3	tisagenlecleucelIBA 03/2022 - 01/2020
3	VaccinesIBA 01/2021 - 09/2005
3	EpitopesIBA 01/2021 - 07/2011
3	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 10/2010
3	Immunoglobulin G (IgG)IBA 01/2021 - 11/2019
3	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 05/2002
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2011
3	Prednisone (Sone)FDA LinkGeneric 01/2018 - 09/2003
3	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 09/2003
3	IodineIBA 01/2018 - 09/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 09/2003
3	TEMPOIBA 01/2015 - 12/2004
3	CD20 AntigensIBA 11/2014 - 02/2005
3	HLA Antigens (Human Leukocyte Antigens)IBA 10/2014 - 02/2010
3	Complement System Proteins (Complement)IBA 02/2005 - 02/2002
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2022 - 09/2002
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2022 - 12/2013
2	PlatinumIBA 01/2022 - 12/2015
2	Melphalan (Alkeran)FDA LinkGeneric 01/2021 - 01/2019
2	Calcineurin InhibitorsIBA 01/2021 - 03/2012
2	Clofarabine (Clolar)FDA Link 01/2021 - 01/2020
2	ibrutinibIBA 01/2020 - 09/2017
2	CytokinesIBA 01/2019 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 12/2016 - 11/2011
2	Biological ProductsIBA 12/2016 - 12/2011
2	ibritumomab tiuxetan (Zevalin)FDA Link 02/2015 - 07/2011
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2015 - 04/2006
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2010 - 02/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2006 - 08/2003
1	ORALIT (ORS)IBA 03/2022
1	Alkylating AgentsIBA 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	B-Cell Maturation AntigenIBA 01/2021

Therapy/Procedure

74	Cell Transplantation 11/2022 - 02/2003
54	Therapeutics 12/2022 - 02/2002
28	Drug Therapy (Chemotherapy) 01/2022 - 01/2003
24	Transplantation 01/2021 - 03/2002
19	Stem Cell Transplantation 01/2022 - 03/2002
15	Immunotherapy 01/2021 - 09/2005
14	Homologous Transplantation 11/2022 - 01/2003
12	Hematopoietic Stem Cell Transplantation 02/2014 - 01/2002
10	Radioimmunotherapy 11/2022 - 05/2002
4	Aftercare (After-Treatment) 12/2022 - 10/2015
4	Autologous Transplantation 12/2015 - 01/2002
2	Induction Chemotherapy 02/2016 - 06/2008
2	Radiotherapy 09/2006 - 09/2003
2	Ligation 02/2002 - 02/2002
1	Platelet Transfusion (Blood Platelet Transfusions) 12/2022